
October 2021
This issue focuses on a unique approach to ferry design, plus more ferry and cruise industry news. Learn about a new rail ferry, how ferry ridership is set to boom, and more!
This issue focuses on a unique approach to ferry design, plus more ferry and cruise industry news. Learn about a new rail ferry, how ferry ridership is set to boom, and more!
A federal judge has granted Florida a preliminary injunction restraining the Centers for Disease Control (CDC) and and Prevention from enforcing its rules on cruise ships in Florida’s ports. Effective July 18,
Shares in Royal Caribbean Group (NYSE: RCL) were up sharply today on news that the U.S. Centers for Disease Control and Prevention has given the group its first green light for test
Carnival Cruise Line is in talks with the Centers for Disease Control and Prevention and is “working towards” restarting sailing in July, the cruise line’s president Christine Duffy said yesterday in an
The U.S. Centers for Disease Control and Prevention has issued the next phase of technical guidance under its Framework for Conditional Sailing Order (CSO). Though it marks another step forward by the
CLIA, which represents 95% of global ocean-going cruise capacity, today called on the Centers for Disease Control and Prevention (CDC) to lift the Framework for Conditional Sailing Order (CSO), issued October 30,
Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK) today reported a U.S. GAAP net loss of $2.2 billion and adjusted net loss of $1.9 billion for the fourth quarter of 2020. The
Finland’s Meyer Turku shipyard delivered the much anticipated LNG-fueled 5,200 passenger cruise ship Mardi Gras to Carnival Cruise Line on December 18. “We are delivering a beautiful and highly advanced ship with
Stocks of cruise lines took a minor hit today, in apparent reaction to reports that a passenger on board SeaDream Yacht Club’s SeaDream 1 had tested positive for COVID-19. The boutique cruise
Prices of cruise lines stocks soared on the New York Stock Exchange today as Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that their mRNA-based vaccine candidate had demonstrated evidence